Use of Favipiravir to Treat Lassa Virus Infection in Macaques
Use of Favipiravir to Treat Lassa Virus Infection in Macaques
About this item
Full title
Author / Creator
Publisher
United States: U.S. National Center for Infectious Diseases
Journal title
Language
English
Formats
Publication information
Publisher
United States: U.S. National Center for Infectious Diseases
Subjects
More information
Scope and Contents
Contents
Lassa virus, the cause of Lassa fever in humans, is endemic to West Africa. Treatment of Lassa fever is primarily supportive, although ribavirin has shown limited efficacy if administered early during infection. We tested favipiravir in Lassa virus-viremic macaques and found that 300 mg/kg daily for 2 weeks successfully treated infection.
Alternative Titles
Full title
Use of Favipiravir to Treat Lassa Virus Infection in Macaques
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_3aecf98e94ba4838974e7b84ddf68363
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3aecf98e94ba4838974e7b84ddf68363
Other Identifiers
ISSN
1080-6040
E-ISSN
1080-6059
DOI
10.3201/eid2409.180233
